This and other data had led to apprehensions regarding the sustainability of hepatitis B vaccination in India's UIP.19 However, in our study, the coverage of this vaccine was close to the well-established vaccines OPV and DPT (60%), emphasising the success of implementation of hepatitis B vaccine over time. The gene discussed is PPIB; the disease is hepatitis B virus infection.